Traders should monitor for potential share dilution as the company resumes its ATM program. The offering size is relatively small ($1.555M), which may limit immediate impact, but sustained sales could pressure the stock price given the company's small market cap of $11M.
Price Chart
Executive Summary
Hoth Therapeutics is resuming its at-the-market (ATM) offering program by filing a new prospectus supplement, after having suspended it in April 2026. The company intends to raise up to $1.555 million in gross proceeds through sales of its common stock.
Key Facts
- Hoth Therapeutics is resuming its at-the-market (ATM) offering program after a brief suspension in April 2026.
- The company plans to file a new prospectus supplement to its S-3 registration statement to raise up to $1.555 million in gross proceeds.
- The legal opinion from Sheppard Mullin confirms the validity of the securities to be issued under the ATM agreement.
- The ATM is being conducted through H.C. Wainwright & Co. as sales agent.
Financial Impact
Up to $1.555 million in gross proceeds from the sale of common stock
Risk Factors
- Dilution risk for existing shareholders as new shares are issued
- Potential downward pressure on stock price due to increased supply in the market
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-044741 |
| Document: ea028671901ex5-1.htm | 0001213900-26-044741 |
| Document: 0001213900-26-044741-index-headers.html | 0001213900-26-044741 |
| Document: 0001213900-26-044741-index.html | 0001213900-26-044741 |
| Document: 0001213900-26-044741.txt | 0001213900-26-044741 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | DEF 14A | — | awaiting T+20 | — | — |
Jun 3, 2026 20w ago | 8-K | $2.14 $0.8880 | ▼ −58.50% | ▼ −57.50% | — |
Jun 3, 2026 20w ago | 8-K | $2.14 $0.8880 | ▲ +58.50% | ▲ +57.50% | — |
Jun 3, 2026 20w ago | 424B5 | $2.14 $0.8880 | ▲ +58.50% | ▲ +57.50% | — |
Jun 2, 2026 20w ago | 8-K | $2.14 $0.8880 | ▼ −58.50% | ▼ −57.50% | — |
May 28, 2026 21w ago | 8-K | $1.70 $0.9508 | ▼ −44.07% | ▼ −41.63% | — |
May 27, 2026 21w ago | 424B5 | $1.70 $0.9508 | ▲ +44.07% | ▲ +41.63% | — |
May 27, 2026 21w ago | 8-K | $1.36 $0.8750 | ▼ −35.66% | ▼ −33.76% | — |
May 4, 2026 25w ago | 8-K | $0.7100 $2.22 | ▼ −212.68% | ▼ −207.72% | — |
Apr 16, 2026 27w ago | 8-K | $0.7300 $0.6660 | ▼ −8.77% | ▼ −14.14% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers